Qiagen (QGEN) EBIT (2009 - 2025)

Qiagen (QGEN) has 17 years of EBIT data on file, last reported at $99.4 million in Q4 2025.

• Quarterly EBIT fell 16.51% year-over-year to $99.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $465.9 million (up 376.76% YoY) and the FY2025 annual result came in at $465.9 million, up 376.76% from the prior year.
• EBIT slipped to $99.4 million in Q4 2025 per QGEN's latest filing, from $129.2 million in the prior quarter.
• The five-year high for EBIT was $656.0 million in Q4 2022, with the low at -$228.4 million in Q2 2024.
• Average EBIT over 5 years is $134.5 million, with a median of $115.3 million recorded in 2025.
• Year-over-year, EBIT soared 278.88% in 2022 and plunged 316.67% in 2024.
• Qiagen's EBIT stood at $173.1 million in 2021, then soared by 278.88% to $656.0 million in 2022, then sank by 83.14% to $110.6 million in 2023, then grew by 7.67% to $119.1 million in 2024, then retreated by 16.51% to $99.4 million in 2025.
• Business Quant data shows QGEN's EBIT at $99.4 million in Q4 2025, $129.2 million in Q3 2025, and $121.9 million in Q2 2025.